Neuron Biopharma SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Neuron Biopharma SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11498
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neuron Biopharma SA (NBP) is a biotechnology company that discovers and develops biosolutions. The company offers pharmaceutical compounds to prevent and treat various neurodegenerative diseases. It discovers and assesses nutraceuticals, and development of diagnostic methods for the treatment of Alzheimer’s disease. NBP’s pharmaceutical products include NST0037, NST0076, NST0078, and NPS0158/163. The company develops research projects for public institutions, biotechnological, pharmaceutical, agro-food and animal health area, among others. It conducts research on the implications of the regulation of cholesterol in the brain. The company operates through universities and pharmaceutical companies. It also operates in the US through its subsidiary. NBP is headquartered in Granada, Spain.

Neuron Biopharma SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuron Biopharma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Neuron Biopharma SA, Medical Devices Deals, 2012 to YTD 2018 9
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Neuron Bio and CIEN Foundation Enter into Agreement 11
Equity Offering 12
Neuron Bio Raises USD3.4 Million in Rights Offering of Shares 12
Neuron Bio Raises USD1 Million in Rights Offering of Shares 13
Neuron Bio to Raise USD2 Million in Private Placement of Shares 14
Neuron Biopharma SA – Key Competitors 15
Neuron Biopharma SA – Key Employees 16
Neuron Biopharma SA – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Key Facts 2
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuron Biopharma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuron Biopharma SA, Deals By Therapy Area, 2012 to YTD 2018 8
Neuron Biopharma SA, Medical Devices Deals, 2012 to YTD 2018 9
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Neuron Bio and CIEN Foundation Enter into Agreement 11
Neuron Bio Raises USD3.4 Million in Rights Offering of Shares 12
Neuron Bio Raises USD1 Million in Rights Offering of Shares 13
Neuron Bio to Raise USD2 Million in Private Placement of Shares 14
Neuron Biopharma SA, Key Competitors 15
Neuron Biopharma SA, Key Employees 16
Neuron Biopharma SA, Other Locations 17

List of Figures
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Neuron Biopharma SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Neuron Biopharma SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Costco Wholesale Corporation:企業の戦略・SWOT・財務情報
    Costco Wholesale Corporation - Strategy, SWOT and Corporate Finance Report Summary Costco Wholesale Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Viskase Companies Inc (VKSC):企業の財務・戦略的SWOT分析
    Viskase Companies Inc (VKSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Trammo Inc:企業の戦略的SWOT分析
    Trammo Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • HanAll Biopharma Co Ltd (009420):企業の財務・戦略的SWOT分析
    Summary HanAll Biopharma Co Ltd (HanAll), formerly HanAll Pharmaceutical Co Ltd, is a developer of generic and specialty drugs for treatment of diseases related to digestive, endocrine, musculoskeletal and urinary system. The company’s pipeline products include HL036, a drug being developed for trea …
  • TransAlta Corporation (TA):電力:M&Aディール及び事業提携情報
    Summary TransAlta Corporation (TransAlta) is an electricity generation company. It owns, operates and develops a divergent fleet of electricity generation assets. It generates electricity from a contracted portfolio of assets using diverse sources such as coal, natural gas, hydro, wind and geotherma …
  • Duke Energy Corporation (DUK):石油・ガス:M&Aディール及び事業提携情報
    Summary Duke Energy Corp (Duke Energy) is an integrated energy utility that undertakes the generation, transmission, distribution and sale of electricity; transportation and sale of natural gas; and provision of related energy services in the Southeast and Midwest regions of the US. It also procures …
  • Blue Cross and Blue Shield Association:企業の戦略的SWOT分析
    Blue Cross and Blue Shield Association - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Zhejiang Hisoar Pharmaceutical Co Ltd (002099):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Hisoar Pharmaceutical Co Ltd (Hisoar) is a pharmaceutical company that offers specialty raw materials, preparations, fine chemicals, dyes and intermediates. The company offers raw drugs such as antibody, anti-virus, sugar-reducing, cardiovascular and worm-driven drugs. It produces f …
  • Sharp Corp (6753):企業の財務・戦略的SWOT分析
    Sharp Corp (6753) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Malayan Flour Mills Berhad:企業の戦略・SWOT・財務分析
    Malayan Flour Mills Berhad - Strategy, SWOT and Corporate Finance Report Summary Malayan Flour Mills Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Sempra Energy (SRE):企業の財務・戦略的SWOT分析
    Sempra Energy (SRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Swisscom Ltd (SCMN):企業の財務・戦略的SWOT分析
    Swisscom Ltd (SCMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Celgene Corp (CELG)-製薬・医療分野:企業M&A・提携分析
    Summary Celgene Corp (Celgene) is an integrated global biopharmaceutical company that carries out the research, development, manufacture and marketing of novel therapies to treat cancer and immune-inflammatory related diseases through gene and protein regulation. Its product portfolio includes Vidaz …
  • Sbarro, LLC:企業の戦略・SWOT・財務情報
    Sbarro, LLC - Strategy, SWOT and Corporate Finance Report Summary Sbarro, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • GrafTech International Ltd:企業の戦略・SWOT・財務情報
    GrafTech International Ltd - Strategy, SWOT and Corporate Finance Report Summary GrafTech International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Younicos AG:電力:M&Aディール及び事業提携情報
    Summary Younicos AG (Younicos), a subsidiary of Aggreko Plc, is a provider of smart energy and grid solutions based on battery storage technology. The company offers Y-Cube plug and play energy storage solution, Y-Station building solution, and Y-Q software platform. It also provides battery packs u …
  • Ishihara Sangyo Kaisha Ltd (4028):企業の財務・戦略的SWOT分析
    Ishihara Sangyo Kaisha Ltd (4028) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Fluor Corporation:戦略・SWOT・企業財務分析
    Fluor Corporation - Strategy, SWOT and Corporate Finance Report Summary Fluor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • CohBar Inc (COB.U):企業の財務・戦略的SWOT分析
    Summary CohBar Inc (CohBar) is a developer of mitochondria based therapeutics. The company develops a class of drugs to treat a wide range of diseases associated with aging and metabolic dysfunction such as non-alcoholic steatohepatitis, obesity, type 2 diabetes, cancer, cardiovascular disease and C …
  • ATLAS Oil Co:石油・ガス:M&Aディール及び事業提携情報
    Summary ATLAS Oil Co (ATLAS) is an oil and gas company that offers fuel supply and logistic services. The company’s services comprise supply, renewable fuels, bulk fueling, fuel on demand, logistics, fixed price contracts, frac site fueling, emergency refuel, crude hauling, transloading and on-site …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆